-
Sep 28, 2012, 10:00 AM
by
Michael Croft
Reason.com | Just in time for next week's big Consumer Genetics Conference in Boston, Ronald Bailey talks about the wonders of consumer genetics.
Full story
-
Sep 28, 2012, 09:00 AM
by
Michael Croft
The Scientist | A pilot program is allowing University of Utah readers to "check out" Nature papers from the library for as little as $3 with the help of Readcube reference management software. Compared to purchasing reprints for $35, the program represents significant savings for researchers.
Full story
-
Sep 28, 2012, 06:05 AM
by
Michael Croft
Bio-IT World | Researchers in Puerto Rico have taken the concept of public funding for genome research to a new level. Paid for with money raised from art and fashion shows and private donations, scientists and students at the University of Puerto Rico at Mayagüez have sequenced the genome of the critically endangered Puerto Rican parrot (Amazona vittata)—and maybe introduced a new model for genome research.
Full story
-
Sep 27, 2012, 15:25 PM
by
Michael Croft
Sacramento Bee | ChemAxon has opened new East coast headquarters in Cambridge, Massachusetts.
Full story
-
Sep 27, 2012, 07:25 AM
by
Michael Croft
Bio-IT World | Knome, the informatics company co-founded by George Church that bills itself as the “human genome interpretation” company, is launching a dedicated “genome supercomputer” designed to sit next to a next-gen sequencer and enhance the interpretation of genome sequences using Knome's proprietary software.
Full story
-
Sep 26, 2012, 14:00 PM
by
Michael Croft
Fast Company | Making their biofuel is a lot like making beer, says Eduardo Loosli, the plant manager at Amyris's Brazilian headquarters. But instead of yeast producing alcohol from sugar, the Amyris genetically modified yeast produce farnesene.
Full story
-
Sep 26, 2012, 12:05 PM
by
Michael Croft
Harvard Business Review | What's the sexiest job in the 21st century? Harvard Business Review says it's data scientist. With all the messy datasets available to us now, sorting through and processing that information is an opportunity for creativity, ingenuity,and some very sexy computing.
Full story
-
Sep 26, 2012, 11:45 AM
by
Michael Croft
Xconomy | As the dust settles on the BGI-Complete Genomics announcements, we can start to consider what the merger means for the industry and genomics-driven medicine.
Full story
-
Sep 26, 2012, 02:05 AM
by
Michael Croft
HHMI | The Howard Hughes Medical Center has chosen 13 basic researchers as recipients of its Senior International Research Scholar (SIRS) awards. Each research scholar will receive a grant of $100,000 per year over five years.
Full story
-
Sep 25, 2012, 11:00 AM
by
Michael Croft
Bio-IT World | BGI and the Bill & Melinda Gates Foundation have signed a Memorandum of Understanding (MOU) to begin immediate collaboration on global health and agricultural development.
Full story
-
Sep 25, 2012, 01:00 AM
by
Michael Croft
Bio-IT World Roundup | There's been much discussion this week of data centers and the virtual cloud's actual impact on the environment.
Full story
-
Sep 24, 2012, 12:55 PM
by
Michael Croft
Cancer Grace | A week after releasing favorable Phase II results for the novel vascular-targeting immunotherapy for non-small cell lung cancer, bavituximab, study sponsor Peregrine Pharmaceuticals has announced "major discrepancies" in the trial.
Full story
-
Sep 24, 2012, 06:55 AM
by
Michael Croft
Bio-IT World | Vienna may be known as the City of Music, but in three weeks it will also be a hub for life sciences, informatics, and IT. Bio-IT World’s fourth European Conference & Expo finds a new home in Vienna, Austria, bringing tracks on drug discovery informatics; data infrastructure and high performance computing; cloud-based bioinformatics and clinical genomics to the heart of Europe.
Full story
-
Sep 21, 2012, 10:00 AM
by
Michael Croft
Forbes | The Allen Brain Atlas published its first results yesterday in Nature, and some were surprising. Gene expression on the right and left sides of the brain looks very similar, but the variety that is there seems to be pretty important.
Full story
-
Sep 21, 2012, 09:00 AM
by
Michael Croft
CNBC | Google Ventures is planning $1 billion of start-up investment in the next five years and it has its eye on biotech.
Full story
-
Sep 21, 2012, 09:00 AM
by
Michael Croft
Xconomy | Third Rock Ventures is investing $38 million in a startup that is targeting the genetic causes of heart problems. MyoKardia will set up shop in San Francisco.
Full story
-
Sep 21, 2012, 08:00 AM
by
Michael Croft
Tulsa World | In addition to $23 million of Series A financing, Selexys Pharmaceuticals Corp. of Oklahoma City has struck an agreement with Novartis that could lead to the company's acquisition for up to $665 million for its sickle cell treatment.
Full story
-
Sep 21, 2012, 07:00 AM
by
Michael Croft
Bio-IT World Video | Bio-IT World Editor Kevin Davies speaks with Dave Weitz, professor of physics at Harvard and speaker at the upcoming Consumer Genomics Conference, about his research on microfluidics, which has applications in everything from next-gen sequencing technology to personalized cosmetics.
Full story
-
Sep 20, 2012, 11:00 AM
by
Michael Croft
Boston Globe | Foundation Medicine announced a $42.5 million Series B financing round this morning thanks to Deerfield Management Company, L.P., Casdin Capital, Redmile Group and strategic investors Roche Venture Fund and WuXi Corporate Venture Fund.
Full story
-
Sep 20, 2012, 05:20 AM
by
Michael Croft
Bio-IT World | A new big pharma collaboration has been launched to identify and solve common drug development challenges, starting with clinical study execution. TransCelerate BioPharma was created by ten companies—Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech (a member of the Roche Group), and Sanofi—all of which have pooled financial, personnel, and other resources to solve industry-wide challenges in a collaborative environment.
Full story